Local regulation of arterial L-type calcium channels by reactive oxygen species

Circulation Research

Volumn 107, Issue 8, 2010, Pages 1002-1010

  Amberg, Gregory C ^a   Earley, Scott ^a   Glapa, Stephanie A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

calcium sparklets; L type calcium channels; protein kinase C; reactive oxygen species

Indexed keywords

CALCIUM CHANNEL L TYPE; PROTEIN KINASE C ALPHA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY CONSTRICTION; ARTERY MUSCLE; ARTICLE; BRAIN ARTERY; CALCIUM TRANSPORT; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; ANIMALS; BASILAR ARTERY; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; MALE; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE C-ALPHA; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 77958454879     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.217018     Document Type: Article

References (40)

1. Adiga IK, Nair RR. Multiple signaling pathways coordinately mediate reactive oxygen species dependent cardiomyocyte hypertrophy. Cell Biochem Funct. 2008;26:346-351.
2. Allen CL, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009;4:461-470.
3. Hordijk PL. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res. 2006;98:453-462.
4. Lee MY, Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal. 2008;10:1045-1059.
5. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008;31(Suppl 2):S170-S180.
6. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem. 2004;279:45935-45941.
7. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol. 2009;302:148-158.
8. Quinn MT, Ammons MC, Deleo FR. The expanding role of NADPH oxidases in health and disease: no longer just agents of death and destruction. Clin Sci (Lond). 2006;111:1-20.
9. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res. 2002;90: 1205-1213.
10. Brown DI, Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med. 2009;47:1239-1253.
11. Helmcke I, Heumuller S, Tikkanen R, Schroder K, Brandes RP. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal. 2009;11:1279-1287.
12. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24: 677-683.
13. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol. 1998;508(Pt 1):199-209.
14. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J. 2003; 22:6027-6034.
15. 2+ concentrations. J Gen Physiol. 1996;107:459-472.
16. Amberg GC, Navedo MF, Nieves-Cintron M, Molkentin JD, Santana LF. Calcium sparklets regulate local and global calcium in murine arterial smooth muscle. J Physiol. 2007;579:187-201.
17. 2+ sparklet activity in arterial smooth muscle. J Gen Physiol. 2006;127:611-622.
18. 2+ channels. Proc Natl Acad Sci USA. 2005;102: 11112-11117.
19. 2+ sparklets and angiotensin II-induced hypertension. Circ Res. 2008;102:e1-e11.
20. 2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension. Proc Natl Acad Sci USA. 2008;105: 15623-15628.
21. Maravall M, Mainen ZF, Sabatini BL, Svoboda K. Estimating intracellular calcium concentrations and buffering without wavelength ratioing. Biophys J. 2000;78:2655-2667.
22. i threshold for translocation of the alpha-protein kinase C isoform. Am J Physiol. 1994;266:C1544-C1551.
23. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal. 2008;10:1115-1126.
24. v1.2 channels are responsible for sparklets in mouse arterial smooth muscle. Am J Physiol Heart Circ Physiol. 2007; 293:H1359-H1370.
25. 2+-and phospholipid- independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA. 1989;86: 6758-6762.
26. Weir EK, Wyatt CN, Reeve HL, Huang J, Archer SL, Peers C. Diphe-nyleneiodonium inhibits both potassium and calcium currents in isolated pulmonary artery smooth muscle cells. J Appl Physiol. 1994;76: 2611-2615.
27. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
28. Wackenfors A, Vikman P, Nilsson E, Edvinsson L, Malmsjo M. Angiotensin II-induced vasodilatation in cerebral arteries is mediated by endothelium-derived hyperpolarising factor. Eur J Pharmacol. 2006;531: 259-263.
29. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol. 1986;250:H822-H827.
30. + channels through different protein kinase C isoenzymes. Cardiovasc Res. 2009;83:493-500.
31. Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol. 2007;292:H2613-H2622.
32. 2+ spark frequency in smooth muscle cells from cerebral arteries. Am J Physiol Cell Physiol. 1997;273:C2090-C2095.
33. 2+ sensitization in triton X-100-demembranated rabbit arterial smooth muscle. J Physiol. 1999;520(Pt 1):139-152.
34. Tabet F, Savoia C, Schiffrin EL, Touyz RM. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol. 2004;44:200-208.
35. Miller AA, Drummond GR, Schmidt HH, Sobey CG. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res. 2005;97:1055-1062.
36. Cox JA, Jeng AY, Sharkey NA, Blumberg PM, Tauber AI. Activation of the human neutrophil nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase by protein kinase C. J Clin Invest. 1985;76: 1932-1938.
37. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation. 2003;108:1253-1258.
38. Knapp LT, Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem. 2000;275:24136-24145.
39. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res. 2002;91:406-413.
40. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension. 2008;51: 211-217.